FASB, GASB Trustees to Discuss New Proposals and Rules The Financial Accounting Foundation (FAF), the governing body responsible for overseeing the development of U.S. Generally Accepted Accounting ...

Ladies and gentlemen, thank you for standing by. My name is Rob, and I’m your event operator today. I’d like to welcome ...

The Financial Accounting Standards Board posted a proposed accounting standards update Wednesday with the goal of improving the requirements for identifying the accounting acquirer in a business ...

Revenue of $2.6 billion, up 3% on an as-reported and FX-Neutral basis Gross Merchandise Volume of $18.3 billion, up 2% on an as-reported basis and up 1% on an FX-Neutral ...

Higher third quarter funds flow from operations of $124.7 million ($1.64 per share) — a 34 percent increase over the third quarter of 2023 on a per share basis 2024 average production expected to be ...

Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales more than doubled year over year to $3.1 billion. Sales for Zepbound, which ...

Q4 2024 Earnings Call Transcript November 2, 2024 Operator: Good day, and welcome to the S&W Seed Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.

Efficient financial management is crucial for business and personal success. As technology continues to evolve, artificial intelligence has emerged in the accounting industry, offering innovative ...

Good day, ladies and gentlemen, and welcome to Exelixis' third quarter 2024 financial results conference call. My name is ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-reports-third-quarter-2024-financial-results-and-raises ...